Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
VISIBLE ALPHA LAUNCHES NEW BIOPHARMA PLATFORM | ||
By: PR Newswire Association LLC. - 06 Feb 2024 | Back to overview list |
|
Delivers One-Stop-Shop for Critical Drug-Level Data and Financial Information to Enable More Informed Investment Decision Making in Rapid-Paced Pharmaceutical and Biotech Industries NEW YORK, Feb. 6, 2024 /PRNewswire/ -- Visible Alpha, a financial technology company that enhances the investment research process by extracting value from sell-side analyst models, research reports and corporate access events, today announced the launch of its newest data and granular financial information platform Visible Alpha BioPharma. The pharmaceutical and biotech industries deliver constant innovation and are rapidly evolving. The demand for accurate and holistic drug-level forecasts is more important than ever before. This demand is amplified by evolving regulations, diverse clinical trial outcomes and frequent market fluctuations. With the launch of Visible Alpha BioPharma, Visible Alpha is providing investment professionals and drug developers with a one-stop-shop for comprehensive drug data and granular financial information to swiftly identify new opportunities, evaluate market competitiveness, gauge market expectations, analyze historical data, access forward-looking estimates and conduct rapid analysis at the drug level. Visible Alpha's new BioPharma platform will allow investment, equity research, and drug development professionals to:
"According to the FDA, we are experiencing a faster pace of innovation and development and more drug approvals in the pharmaceutical and biotech industries," said Mark Hale, CEO of Visible Alpha. "In creating Visible Alpha's BioPharma platform, we are enabling investment professionals the ability to not only keep pace, but to enhance the speed of strategic investment decision making through granular financial information on thousands of drugs – all in an interactive platform that allows for exploration and discovery. We are thrilled to bring this incredibly robust and feature rich platform to our clients." The new Visible Alpha BioPharma platform features the following functionality:
Today's announcement follows recent news of Visible Alpha's continued growth of sell-side institution contributors. Learn more > About Visible Alpha Visible Alpha enhances the investment research process by extracting meaningful value from key sell-side assets, including analyst models, research reports and corporate access events through partnerships with the world's premier investment research organizations. Our deep consensus data provides granular and timely insights into the sell-side view of companies, industries and peer groups. For more information, visit visiblealpha.com. Media Contact: Erin Gifford Logo - https://mma.prnewswire.com/media/2334517/Visible_Alpha_Logo.jpg View original content:https://www.prnewswire.co.uk/news-releases/visible-alpha-launches-new-biopharma-platform-302053931.html |
||
|
||
Copyright 2024 PR Newswire Association LLC. | Back to overview list |